A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

Clinical trial NCT06104124 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06104124
Sponsor: Amgen
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sjogren's Syndrome

Start date: 2024-01-24
Primary completion: 2026-08-19
Enrollment: 651

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.